3-Hydroxyphencyclidine (3-HPC), a metabolite of phencyclidine (PCP), is increasingly attracting clinical attention due to initial data suggesting distinct physiological properties. Current research suggest that 3-HPC may display distinct impacts on the central structure, possibly playing a role t